[English] 日本語

- EMDB-45577: Cryo-EM Structural Analysis of Human Integrin Heterodimer bound t... -
+
Open data
-
Basic information
Entry | ![]() | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Cryo-EM Structural Analysis of Human Integrin Heterodimer bound to DNA Aptamer | |||||||||
![]() | ||||||||||
![]() |
| |||||||||
![]() | DNA aptamer / Human integrin / Cryo-EM / CELL ADHESION | |||||||||
Function / homology | Isoform 1 of Integrin beta-1 / Isoform 1 of Integrin alpha-4![]() | |||||||||
Biological species | ![]() | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.5 Å | |||||||||
![]() | Wang T | |||||||||
Funding support | 1 items
| |||||||||
![]() | ![]() Title: DNA Aptamer-Polymer Conjugates for Selective Targeting of Integrin α4β1 T-Lineage Cancers. Authors: Ian I Cardle / Jai Raman / Dinh Chuong Nguyen / Tong Wang / Abe Y Wu / Drew L Sellers / Trey J Pichon / Emmeline L Cheng / Nataly Kacherovsky / Stephen J Salipante / Michael C Jensen / Suzie H Pun / ![]() Abstract: Selective therapeutic targeting of T-cell malignancies is difficult due to the shared lineage between healthy and malignant T cells. Current front-line chemotherapy for these cancers is largely ...Selective therapeutic targeting of T-cell malignancies is difficult due to the shared lineage between healthy and malignant T cells. Current front-line chemotherapy for these cancers is largely nonspecific, resulting in frequent cases of relapsed/refractory disease. The development of targeting approaches for effectively treating T-cell leukemia and lymphoma thus remains a critical goal for the oncology field. Here, we report the discovery of a DNA aptamer, named HR7A1, that displays low nanomolar affinity for the integrin α4β1 (VLA-4), a marker associated with chemoresistance and relapse in leukemia patients. After truncation of HR7A1 to a minimal binding motif, we demonstrate elevated binding of the aptamer to T-lineage cancer cells over healthy immune cells. Using cryo-EM and competition studies, we find that HR7A1 shares an overlapping binding site on α4β1 with fibronectin and VCAM-1, which has implications for sensitizing blood cancers to chemotherapy. We last characterize barriers to aptamer translation, including serum stability, temperature-sensitive binding, and short circulation half-life, and synthesize an aptamer-polymer conjugate that addresses these challenges. Future work will seek to validate targeting of α4β1 tumors with the conjugate, establishing an aptamer-based biomaterial that can be readily adapted for targeted treatment of T-cell malignancies. | |||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 54 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 17.2 KB 17.2 KB | Display Display | ![]() |
FSC (resolution estimation) | ![]() | 11.7 KB | Display | ![]() |
Images | ![]() | 98.5 KB | ||
Filedesc metadata | ![]() | 6.1 KB | ||
Others | ![]() ![]() | 59.4 MB 59.4 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Validation report
Summary document | ![]() | 742.5 KB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 742.1 KB | Display | |
Data in XML | ![]() | 15.5 KB | Display | |
Data in CIF | ![]() | 20.7 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Similar structure data | Similarity search - Function & homology ![]() |
---|
-
Links
EMDB pages | ![]() ![]() |
---|
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.8465 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Half map: #1
File | emd_45577_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: #2
File | emd_45577_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : human integrin alpha4 beta1 heterodimer in complex with DNA aptamer
Entire | Name: human integrin alpha4 beta1 heterodimer in complex with DNA aptamer |
---|---|
Components |
|
-Supramolecule #1: human integrin alpha4 beta1 heterodimer in complex with DNA aptamer
Supramolecule | Name: human integrin alpha4 beta1 heterodimer in complex with DNA aptamer type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 320 KDa |
-Macromolecule #1: DNA aptamer
Macromolecule | Name: DNA aptamer / type: dna / ID: 1 / Classification: DNA |
---|---|
Source (natural) | Organism: synthetic construct (others) |
Sequence | String: CTCCTTACTA GATGCAACCC GACTACTAAC GTCGTAAGAG AG |
-Macromolecule #2: human integrin alpha 4
Macromolecule | Name: human integrin alpha 4 / type: protein_or_peptide / ID: 2 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Recombinant expression | Organism: ![]() |
Sequence | String: YNVDTESALL YQGPHNTLFG YSVVLHS HG ANRWLLVGAP TANWLANASV INPGAIYRCR IGKNPGQTCE QLQLGSPNGE PCGKTCLE E RDNQWLGVTL SRQPGENGSI VTCGHRWKNI FYIKNENKLP TGGCYGVPPD LRTELSKRI APCYQDYVKK FGENFASCQA ...String: YNVDTESALL YQGPHNTLFG YSVVLHS HG ANRWLLVGAP TANWLANASV INPGAIYRCR IGKNPGQTCE QLQLGSPNGE PCGKTCLE E RDNQWLGVTL SRQPGENGSI VTCGHRWKNI FYIKNENKLP TGGCYGVPPD LRTELSKRI APCYQDYVKK FGENFASCQA GISSFYTKDL IVMGAPGSSY WTGSLFVYNI TTNKYKAFLD KQNQVKFGS YLGYSVGAGH FRSQHTTEVV GGAPQHEQIG KAYIFSIDEK ELNILHEMKG K KLGSYFGA SVCAVDLNAD GFSDLLVGAP MQSTIREEGR VFVYINSGSG AVMNAMETNL VG SDKYAAR FGESIVNLGD IDNDGFEDVA IGAPQEDDLQ GAIYIYNGRA DGISSTFSQR IEG LQISKS LSMFGQSISG QIDADNNGYV DVAVGAFRSD SAVLLRTRPV VIVDASLSHP ESVN RTKFD CVENGWPSVC IDLTLCFSYK GKEVPGYIVL FYNMSLDVNR KAESPPRFYF SSNGT SDVI TGSIQVSSRE ANCRTHQAFM RKDVRDILTP IQIEAAYHLG PHVISKRSTE EFPPLQ PIL QQKKEKDIMK KTINFARFCA HENCSADLQV SAKIGFLKPH ENKTYLAVGS MKTLMLN VS LFNAGDDAYE TTLHVKLPVG LYFIKILELE EKQINCEVTD NSGVVQLDCS IGYIYVDH L SRIDISFLLD VSSLSRAEED LSITVHATCE NEEEMDNLKH SRVTVAIPLK YEVKLTVHG FVNPTSFVYG SNDENEPETC MVEKMNLTFH VINTGNSMAP NVSVEIMVPN SFSPQTDKLF NILDVQTTT GECHFENYQR VCALEQQKSA MQTLKGIVRF LSKTDKRLLY CIKADPHCLN F LCNFGKME SGKEASVHIQ LEGRPSILEM DETSALKFEI RATGFPEPNP RVIELNKDEN VA HVLLEGL HHQRPKRYFT UniProtKB: Isoform 1 of Integrin alpha-4 |
-Macromolecule #3: human integrin beta 1
Macromolecule | Name: human integrin beta 1 / type: protein_or_peptide / ID: 3 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: ![]() |
Recombinant expression | Organism: ![]() |
Sequence | String: QTDENRCLKA NAKSCGECIQ AGPNCGWCTN STFLQEGMPT SARCDDLEA LKKKGCPPDD IENPRGSKDI KKNKNVTNRS KGTAEKLKPE DITQIQPQQL V LRLRSGEP QTFTLKFKRA EDYPIDLYYL MDLSYSMKDD LENVKSLGTD LMNEMRRITS DF RIGFGSF ...String: QTDENRCLKA NAKSCGECIQ AGPNCGWCTN STFLQEGMPT SARCDDLEA LKKKGCPPDD IENPRGSKDI KKNKNVTNRS KGTAEKLKPE DITQIQPQQL V LRLRSGEP QTFTLKFKRA EDYPIDLYYL MDLSYSMKDD LENVKSLGTD LMNEMRRITS DF RIGFGSF VEKTVMPYIS TTPAKLRNPC TSEQNCTSPF SYKNVLSLTN KGEVFNELVG KQR ISGNLD SPEGGFDAIM QVAVCGSLIG WRNVTRLLVF STDAGFHFAG DGKLGGIVLP NDGQ CHLEN NMYTMSHYYD YPSIAHLVQK LSENNIQTIF AVTEEFQPVY KELKNLIPKS AVGTL SANS SNVIQLIIDA YNSLSSEVIL ENGKLSEGVT ISYKSYCKNG VNGTGENGRK CSNISI GDE VQFEISITSN KCPKKDSDSF KIRPLGFTEE VEVILQYICE CECQSEGIPE SPKCHEG NG TFECGACRCN EGRVGRHCEC STDEVNSEDM DAYCRKENSS EICSNNGECV CGQCVCRK R DNTNEIYSGK FCECDNFNCD RSNGLICGGN GVCKCRVCEC NPNYTGSACD CSLDTSTCE ASNGQICNGR GICECGVCKC TDPKFQGQTC EMCQTCLGVC AEHKECVQCR AFNKGEKKDT CTQECSYFN ITKVESRDKL PQPVQPDPVS HCKEKDVDDC WFYFTYSVNG NNEVMVHVVE N PECPTGPD UniProtKB: Isoform 1 of Integrin beta-1 |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Buffer | pH: 7 |
---|---|
Grid | Model: Quantifoil R0.6/1 / Material: COPPER / Mesh: 300 / Support film - Material: CARBON / Support film - topology: HOLEY ARRAY / Pretreatment - Type: PLASMA CLEANING / Pretreatment - Time: 60 sec. |
Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
Microscope | FEI TITAN |
---|---|
Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 76.56 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | C2 aperture diameter: 70.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 1.6 µm / Nominal defocus min: 0.9 µm / Nominal magnification: 37000 |
Sample stage | Specimen holder model: GATAN 626 SINGLE TILT LIQUID NITROGEN CRYO TRANSFER HOLDER Cooling holder cryogen: NITROGEN |